Peacock Tariff Consulting works with Antwerp-region Belgian exporters across chemicals and petrochemicals, plastics, specialty chemicals, pharmaceuticals (Janssen, GSK Belgium), and the diamond trade. Antwerp is Europe’s #2 container port and the world’s #1 chemical cluster outside Houston.
Antwerp chemical exporters face a specific set of U.S. pain points – Section 232 derivatives, AD/CVD on specialty chemicals, BIS export controls for dual-use materials. Belgian pharma (Janssen, GSK Belgium) adds a Section 232 pharma layer. This cluster is underserved by North American advisors.
Peacock Tariff Consulting works with Belgian exporters across these clusters.
Belgian chemical 232 derivatives scan
Section 232 derivatives expansion brings some chemical products into scope. Component-level scope analysis identifies actual exposure.
AD/CVD on specialty chemicals
U.S. AD/CVD orders on specialty chemicals affect specific products and origins. Belgian-origin chemicals sometimes face AD/CVD; sometimes scope rulings can confirm exemption.
Belgian pharma 232 readiness
Janssen, GSK Belgium, and other Belgian pharma operations face Section 232 pharma effective July 31, 2026 with tiered rates. Generics and biosimilars excluded; branded patented drugs covered.
Dual-use BIS controls for Antwerp shippers
Dual-use chemicals subject to BIS export controls require careful documentation. Tariff layer plus export controls layer = coordination work.
Antwerp-to-U.S. routing decision tree
East Coast vs. Gulf Coast routing for Belgian-origin chemicals affects logistics cost; tariff treatment is largely identical across U.S. ports.
Frequently asked questions
Do you handle Section 232 chemical derivative scope?
Yes. Component-level scope analysis is a focused engagement type for chemical exporters.
Can you handle AD/CVD work on specialty chemicals?
Yes. AD/CVD scope rulings, individual rate determinations, and protest filings are all areas we cover.
How does BIS export controls affect tariff work?
BIS controls are parallel to tariff treatment. We coordinate the tariff layer with export controls counsel.
Do you serve Janssen pharma adjacencies?
Yes. Belgian pharma Section 232 readiness is one of our active engagements for the Antwerp market.
Are you affiliated with Essenscia or any Belgian industry body?
No. We are independent.
Get started
Book a Belgian chemical exporter tariff review.